Literature DB >> 25696549

Selection of patients for cardiac resynchronisation therapy (CRT) in an unselected heart failure population.

C M H B Lucas, G V J Cleuren, C J H J Kirchhof.   

Abstract

BACKGROUND: In patients with chronic heart failure (CHF), the presence of conduction delay across the myocardium is a well-known feature. During recent years an increasing number of CHF patients have been treated with cardiac resynchronisation therapy (CRT). So far in many protocols patients have been selected using the criteria of left ventricular ejection fraction (LVEF) ≤35% concomitant with signs of widening of the QRS on the surface electrocardiogram, either with or without left bundle branch block (LBBB) morphology.
METHODS: In this article we discuss which of the patients admitted with CHF to a regular cardiology practice could be candidates for this therapy. Data were obtained from January 2000 to December 2004 on a total of 861 CHF patients, of whom 309 had an LVEF ≤35%. Of these patients, 123 patients showed a QRS width >120 msec, while 81 patient had a QRS width >140 msec. In total, 89 patients had an LBBB morphology on the electrocardiogram, while 21 patients had univentricular pacing devices in situ. In those patients with an LVEF >35%, QRS width was 108±27msec.
CONCLUSION: A substantial number of patients presenting with CHF in a regular cardiology practice are suitable candidates for CRT therapy according to currently used criteria of QRS width and LVEF. This number could be increased even more if recent information concerning intraventricular conduction delay in CHF patients with less widening of the QRS complex were to be applied, as judged by echocardiographic techniques.

Entities:  

Keywords:  conduction delay; heart failure; pacing device

Year:  2006        PMID: 25696549      PMCID: PMC2557224     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN: 1568-5888            Impact factor:   2.380


  20 in total

1.  Left ventricular versus biventricular dysfunction in idiopathic dilated cardiomyopathy.

Authors:  L La Vecchia; M Paccanaro; C Bonanno; L Varotto; R Ometto; M Vincenzi
Journal:  Am J Cardiol       Date:  1999-01-01       Impact factor: 2.778

2.  Cardiac resynchronization in chronic heart failure.

Authors:  William T Abraham; Westby G Fisher; Andrew L Smith; David B Delurgio; Angel R Leon; Evan Loh; Dusan Z Kocovic; Milton Packer; Alfredo L Clavell; David L Hayes; Myrvin Ellestad; Robin J Trupp; Jackie Underwood; Faith Pickering; Cindy Truex; Peggy McAtee; John Messenger
Journal:  N Engl J Med       Date:  2002-06-13       Impact factor: 91.245

Review 3.  Echocardiographic evaluation of cardiac resynchronization therapy: ready for routine clinical use? A critical appraisal.

Authors:  Jeroen J Bax; Gerardo Ansalone; Ole A Breithardt; Genevieve Derumeaux; Christophe Leclercq; Martin J Schalij; Peter Sogaard; Martin St John Sutton; Petros Nihoyannopoulos
Journal:  J Am Coll Cardiol       Date:  2004-07-07       Impact factor: 24.094

4.  Asynchronous electrical activation induces asymmetrical hypertrophy of the left ventricular wall.

Authors:  M F van Oosterhout; F W Prinzen; T Arts; J J Schreuder; W Y Vanagt; J P Cleutjens; R S Reneman
Journal:  Circulation       Date:  1998-08-11       Impact factor: 29.690

5.  Long-term effectiveness of cardiac resynchronization therapy in patients with refractory heart failure and "narrow" QRS.

Authors:  Augusto Achilli; Massimo Sassara; Sabina Ficili; Daniele Pontillo; Paola Achilli; Claudio Alessi; Stefano De Spirito; Roberto Guerra; Nicolino Patruno; Francesco Serra
Journal:  J Am Coll Cardiol       Date:  2003-12-17       Impact factor: 24.094

6.  Intra-left ventricular electromechanical asynchrony. A new independent predictor of severe cardiac events in heart failure patients.

Authors:  Hugues Bader; Stephane Garrigue; Stephane Lafitte; Sylvain Reuter; Pierre Jaïs; Michel Haïssaguerre; Jacques Bonnet; Jacques Clementy; Raymond Roudaut
Journal:  J Am Coll Cardiol       Date:  2004-01-21       Impact factor: 24.094

7.  Improvement of left ventricular function after cardiac resynchronization therapy is predicted by tissue Doppler imaging echocardiography.

Authors:  Martin Penicka; Jozef Bartunek; Bernard De Bruyne; Marc Vanderheyden; Marc Goethals; Marc De Zutter; Pedro Brugada; Peter Geelen
Journal:  Circulation       Date:  2004-02-09       Impact factor: 29.690

8.  Electrocardiographic predictors of arrhythmic death and total mortality in the multicenter unsustained tachycardia trial.

Authors:  Peter J Zimetbaum; Alfred E Buxton; William Batsford; John D Fisher; Gail E Hafley; Kerry L Lee; Michael F O'Toole; Richard L Page; Matthew Reynolds; Mark E Josephson
Journal:  Circulation       Date:  2004-08-02       Impact factor: 29.690

9.  Natural history of abnormal conduction and its relation to prognosis in patients with dilated cardiomyopathy.

Authors:  H B Xiao; C Roy; S Fujimoto; D G Gibson
Journal:  Int J Cardiol       Date:  1996-02       Impact factor: 4.164

10.  Prevalence of QRS prolongation in a community hospital cohort of patients with heart failure and its relation to left ventricular systolic dysfunction.

Authors:  Roopinder Sandhu; Robert C Bahler
Journal:  Am J Cardiol       Date:  2004-01-15       Impact factor: 2.778

View more
  1 in total

1.  Eligibility for cardiac resynchronization therapy in patients hospitalized with heart failure.

Authors:  Joanna Osmanska; Nathaniel M Hawkins; Mustafa Toma; Andrew Ignaszewski; Sean A Virani
Journal:  ESC Heart Fail       Date:  2018-06-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.